A new nomogram to predict minimal prostate cancer (tumors of less than 0.5 cm3, organ-confined disease and no Gleason pattern 4 or 5) has been developed. O'Brien et al. used preoperative data from 2,525 Australian men, and compared accuracy and error rates to the contemporary Epstein criteria and the Prostate Cancer Research International: Active Surveillance trial inclusion criteria. 152 men had minimal cancer at prostatectomy and the predictive accuracy of the nomogram was 93.3%, compared to 89.1% and 91.0% for the Epstein criteria and the Prostate Cancer Research International: Active Surveillance trial inclusion criteria, respectively.
ORIGINAL RESEARCH PAPER
O'Brien, B. A. et al. A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance. J. Urol. 186, 1811–1817 (2011)
Rights and permissions
About this article
Cite this article
New preoperative nomogram predicts minimal disease. Nat Rev Urol 8, 650 (2011). https://doi.org/10.1038/nrurol.2011.188
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.188
